Evidence map›Paper›PMID 20721601›Full record

ArticleJournal of computer-aided molecular design2010

QMOD: physically meaningful QSAR.

Ajay N Jain

Open access · greenAbstract read
In one paragraph

Article in Journal of computer-aided molecular design, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Extrapolative prediction using physically-based QSAR.Journal of computer-aided molecular design · 2016
    Article
  4. Article
  5. Article
  6. Does your model weigh the same as a duck?Journal of computer-aided molecular design · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Ajay N JainDepartment of Bioengineering and Therapeutic Sciences, Helen Diller Family Comprehensive Cancer Center, University of California, 1450 3rd Street, Room D373, MC 0128, P.O. Box 589001, San Francisco, CA 94158-9001, USA. ajain@jainlab.org
UCSF Helen Diller Family Comprehensive Cancer Center · US

Funding

Machine Learning in Chemistry and BiologyR01GM070481 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JAIN, AJAY N · 2005 to 2013
$2.5M
NIGMS NIH HHS GM070481NIGMS NIH HHS R01 GM070481
6 · The paper itself

Abstract

Computational methods for predicting ligand affinity where no protein structure is known generally take the form of regression analysis based on molecular features that have only a tangential relationship to a protein/ligand binding event. Such methods have utility in retrospective rationalization of activity patterns of substituents on a common scaffold, but are limited when either multiple scaffolds are present or when ligand alignment varies significantly based on structural changes. In addition, such methods generally assume independence and additivity of effect from scaffold substituents. Collectively, these non-physical modeling assumptions sharply limit the utility of widely used QSAR approaches for prospective prediction of ligand activity. The recently introduced Surflex-QMOD approach, by virtue of constructing physical models of binding sites, comes closer to a modeling approach that is congruent with protein ligand binding events. A set of congeneric CDK2 inhibitors showed that induced binding pockets can be quite congruent with the enzyme's active site but that model predictivity within a chemical series does not necessarily depend on congruence. Muscarinic antagonists were used to show that the QMOD approach is capable of making accurate predictions in cases where highly non-additive structure activity effects exist. The QMOD method offers a means to go beyond non-causative correlations in QSAR analysis.

Indexed as

Quantitative Structure-Activity RelationshipBinding SitesComputer SimulationCyclin-Dependent Kinase 2Enzyme InhibitorsLigandsModels, BiologicalModels, MolecularProtein BindingStaurosporineCyclin-Dependent Kinase 2Enzyme InhibitorsLigandsStaurosporine

Identifiers

PMID20721601
PMCPMC3109424
OpenAlexW2033204238

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.